Physician profile

Laura Adams

Obstetrics & Gynecology · San Angelo, TX

NPI 1871575951

$2,935.25

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$127.17

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $2,585.10 2022
Abbvie INC. $84.15 2019-2022
Coopersurgical, INC. $57.02 2021-2022
Daiichi Sankyo INC. $44.82 2022
Innovation Technologies INC $39.49 2023 Irrisept
Dexcom, INC. $37.45 2023-2024 Dexcom G6 Transmitter
Myovant Sciences INC. $36.99 2022
Pacira Pharmaceuticals Incorporated $22.29 2024 Exparel
Minerva Surgical, INC $14.60 2024
Novo Nordisk INC $13.34 2024 Wegovy

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Laura Adams

$2,935.25

in general payments reported 2019-2025

Years
2019-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/266901/laura-adams

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.